Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: González-Ramírez, Marielaa | Gavilán, Javierab | Silva-Grecchi, Tiareb | Cajas-Madriaga, Daniela | Triviño, Sergioa | Becerra, Joséa | Saez-Orellana, Franciscob | Pérez, Claudiaa; * | Fuentealba, Jorgeb; *
Affiliations: [a] Laboratory of Chemistry of Natural Products, University of Concepción, Concepción, Chile | [b] Laboratory of Screening of Neuroactive Compounds, University of Concepción, Concepción, Chile
Correspondence: [*] Correspondence to: Jorge Fuentealba, Laboratory of Screening of Neuroactive Compounds, University of Concepción, Concepción, Chile. E-mail: [email protected] and Claudia Perez, Laboratory of Chemistry of Natural Products, University of Concepción, Concepción, Chile. E-mail: [email protected].
Abstract: Alzheimer’s disease (AD) is characterized by amyloid plaques that form due to an increase in amyloid-β peptide (Aβ) aggregation. One strategy in the search of new treatments for AD focuses on compounds that decrease Aβ accumulation. Compounds containing a benzofuran ring have been described to play an important role in decreasing Aβ-induced toxicity; however, only synthetic benzofurans have been tested thus far. The aim of the present study was to examine the in vitro neuroprotective properties of fomannoxin (Fx), a natural benzofuran isolated from cultures of the Andean-Patagonian fungi Aleurodiscus vitellinus, and evaluate its effect on Aβ peptide. We tested the effect of Fx at a wide concentration range (10–11–10–4 M) in PC-12 cells, and found the compound did not alter cellular viability. Fx also showed a concentration-dependent effect on the Aβ-induced toxicity in PC12 cells, showing viability above 100% at 10–6 M. We then measured the effect of Fx (10–7–10–5 M) on the frequency of cytosolic Ca2+ transients in rat hippocampal neurons at both acute and chronic (24 h) times. Acute incubation with Fx increased the frequency of cytosolic Ca2+ transients to values around 200%, whereas chronic incubation with Fx increased the frequency of Ca2+ transients. Finally, the Aβ-induced decrease in intracellular Ca2+ transients was prevented when Fx (10–6 M) was co-incubated with Aβ (5×10–6 M). The results suggest a potent neuroprotective effect of this naturally occurring benzofuran against Aβ peptide toxicity that could be mediated by an interference with it binding to plasma membrane, and lead Fx as new chemical entity to develop pharmacological tools against Aβ peptide neurotoxicity.
Keywords: Alzheimer’s disease, Aβ peptide inhibitor, benzofuran, fomannoxin
DOI: 10.3233/JAD-170958
Journal: Journal of Alzheimer's Disease, vol. 61, no. 4, pp. 1463-1475, 2018
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]